Akso Health Group (FRA:8HX)

Akso Health Group Ratios and Metrics

Market cap in millions EUR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 20, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	980	393	157	7	35	26
Market Cap Growth	188.91%	150.09%	2005.36%	-78.52%	35.68%	37.80%
Enterprise Value	973	315	158	7	32	24
Last Close Price	1.15	1.05	1.05	0.25	1.53	1.43
PS Ratio	77.49	28.77	70.29	0.62	6.44	-
PB Ratio	5.80	2.13	1.23	0.92	3.15	1.74
P/TBV Ratio	6.37	2.36	1.23	0.93	3.15	1.74
P/FCF Ratio	-	415.76	125.59	-	-	2.99
P/OCF Ratio	158.49	361.20	125.59	-	-	2.99
EV/Sales Ratio	77.20	23.05	70.65	0.59	5.86	-
EV/FCF Ratio	-6.77	333.10	126.24	-	-	2.80
Debt / Equity Ratio	0.01	0.01	0.01	1.10	3.03	0.75
Debt / FCF Ratio	-	2.04	1.48	-	-	1.29
Net Debt / Equity Ratio	-0.05	-0.87	-0.60	0.20	1.53	-0.12
Net Debt / EBITDA Ratio	6.20	98.21	-	-0.12	-7.70	1.04
Net Debt / FCF Ratio	0.05	-170.28	-61.55	-0.54	-2.17	-0.21
Asset Turnover	0.07	0.08	0.03	0.32	0.13	-
Inventory Turnover	75.23	78.96	2.44	2.51	-	-
Quick Ratio	1.19	12.83	23.70	1.34	0.37	1.67
Current Ratio	1.53	14.20	39.52	1.76	1.24	2.09
Return on Equity (ROE)	-68.29%	-80.26%	-12.38%	-123.87%	-27.75%	-13.13%
Return on Assets (ROA)	-1.42%	-1.37%	-6.64%	-21.42%	-3.25%	-2.33%
Return on Invested Capital (ROIC)	-2.55%	-9.78%	-26.24%	-68.50%	-10.64%	-5.26%
Return on Capital Employed (ROCE)	-2.40%	-2.00%	-6.20%	-161.40%	-20.00%	-12.10%
Earnings Yield	-11.80%	-31.75%	-5.57%	-16.75%	-43.61%	-115.74%
FCF Yield	-14.65%	0.24%	0.80%	-40.08%	-22.33%	33.43%
Buyback Yield / Dilution	-204.20%	-504.37%	-106.30%	-15.07%	-22.06%	-0.17%
Total Shareholder Return	-204.20%	-504.37%	-106.30%	-15.07%	-22.06%	-0.17%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.